Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Conglomerate Fosun Has Hong Kong IPO

publication date: Jul 10, 2007
Implications for Chinese Pharmaceutical Industry Last week, the giant Chinese conglomerate Fosun International staged a very successful IPO on the Hong Kong exchange. The sprawling company invited comparisons to the legendary Hutchison Whampao empire in Hong Kong, and demand was further spurred by word that Saudi Prince Alwaleed bin Talal, former AIG CEO Hank Greenberg, and Hutchison Wampao's legendary Li Ka-shing would each take a piece of the offering. More details...


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital